Experimental Lilly drug neutralises Omicron in lab; slightly higher risk of diabetes seen in kids…
The drug, known as LY-CoV1404 or Bebtelovimab, "potently" neutralised engineered versions of numerous variants, including Alpha,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
clinical trial
Covaxin demonstrates robust safety and immunogenicity in two-to-18 year old: Study
Bharat Biotech had conducted phase-II/III, open-label and multi-centre studies to evaluate the safety, reactogenicity and…
US FDA approves Takeda’s Livtencity to treat people with post-transplant Cytomegalovirus infection
In the phase-III Solstice study, more than twice the proportion of adult transplant recipients with refractory or resistant (R/R)…
Bharat Biotech’s US partner Ocugen files request with FDA for Covaxin trials
The development comes a day after the World Health Organization (WHO) sought more details from Bharat Biotech to consider its…
Pfizer-BioNTech phase-III trial data shows high efficacy of a booster dose of their COVID-19 vaccine
First results from any randomised, controlled COVID-19 vaccine booster trial demonstrate a relative vaccine efficacy of 95.6 per…
Vaccines offer strong protection against death from COVID-19 Delta variant
The research, involving the University of Strathclyde, has found that the Pfizer-BioNTech vaccine is 90 per cent effective and the…
Valneva reports positive phase-III results for inactivated, adjuvanted COVID-19 vaccine candidate…
VLA2001 was well-tolerated, demonstrating a statistically significant better tolerability profile compared to active comparator…
FDA approves Verzenio as the first and only CDK4/6 inhibitor for certain people with HR+HER2-…
Verzenio phase-III monarchE trial is a randomised (1:1), open-label, two cohort, multi-centre study in adult women and men with…
Biological E seeks DCGI’s nod for phase-III trial of Corbevax as booster dose in those…
Currently, phase-II/III clinical trials of the second indigenously developed Corbevax is underway and the results are likely to be…
DCGI gives nod to Cadila Healthcare to conduct phase-III trials for two-dose COVID vaccine
The company has already received the Emergency Use Authorisation (EUA) from the Drug Controller General of India (DCGI) for…